Showing results for "Catalent"
markets
Ares (ARES), Blue Owl Lead $4.8 Billion Private Debt for Catalent (CTLT) DealAres Management Corp. and Blue Owl Capital Inc. are leading a group of private credit lenders providing $4.8 billion of debt financing for the acquisition of pharmaceuticals manufacturer Catalent Inc., according to people with knowledge of the matter.April 5, 2024
industries
Ozempic, Novo’s $1,000 Diabetes Drug, Can Be Made for Less Than $5 a MonthOzempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000 in the US, according to a study that revives questions about prices for top-selling treatments for diabetes and obesity.March 27, 2024